LASA SUPERGENERICS LTD Financial Ratios
LASA · Healthcare · Current price ₹5.1
P/E ratio
0.0x
P/B ratio
0.6x
ROE
-68.7%
ROCE
-57.6%
Debt / Equity
0.20
Dividend yield
3.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 0.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -68.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -57.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.20 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with LASA SUPERGENERICS LTD's latest numbers.
LASA SUPERGENERICS LTD profitability
LASA SUPERGENERICS LTD generates a return on equity of -68.7% and a return on capital employed of -57.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.20 and a P/E of 0.0x, LASA SUPERGENERICS LTD is conservatively financed. Our overall business-quality score for the company is 2.7 / 10.
Understand the ratios
More on LASA SUPERGENERICS LTD
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.